Navigation Links
Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors
Date:10/22/2010

and uncertainties, and actual results could differ materially from those discussed. Factors that could cause or contribute to such differences include, but are not limited to: (i) market makers not continuing to make a market in the Company's common stock, (ii) the ability of the Company's common stock to be quoted on the OTCQB, (iii) the Company's ability to continue as a going concern, (iv) the Company's ability to service its principal and interest obligations on its outstanding debt or otherwise renegotiate or refinance such outstanding debt, which renegotiation may not be successful and refinancing may not be available on acceptable terms, if at all, which may trigger defaults under its other debt agreements, create liquidity issues, potentially force the Company to file for protection from its creditors under Chapter 11 of the U.S. Bankruptcy Code and prevent the Company from continuing as a going concern; (iv) the risk that we may not have sufficient funds to operate our business; (v) our success in attracting new business and retaining existing clients and projects; (vi) the size, duration and timing of clinical trials we are currently managing may change unexpectedly; (vii) the termination, delay or cancellation of clinical trials we are currently managing could cause revenues and cash-on-hand to decline unexpectedly; (viii) the timing difference between our receipt of contract milestone or scheduled payments and our incurring costs to manage these trials; (ix) outsourcing trends in the pharmaceutical, biotechnology and medical device industries; (x) the ability to maintain profit margins in a competitive marketplace; (xi) our ability to attract and retain qualified personnel; (xii) the sensitivity of our business to general economic conditions; (xiii) other economic, competitive, governmental and technological factors affecting our operations, markets, products, services and prices; (xiv) announced awards received from existing and potential
'/>"/>
SOURCE Encorium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
2. Encorium Reports Third Quarter 2008 Financial Results
3. Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
4. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
5. Encorium Group Signs Approximately $2.0 Million of New Business Contracts
6. Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award
7. Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team
8. Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business
9. Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes
10. Encorium Reports Second Quarter 2009 Financial Results
11. Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... LA JOLLA, Calif. , July 30, 2014 /PRNewswire/ ... RGLS ), a biopharmaceutical company leading the discovery and ... it will report financial results and highlights for the ... 2014, after the U.S. financial markets close. ... on Wednesday, August 6, 2014, at 5:00 pm Eastern ...
(Date:7/30/2014)... and PARIS , July 30, ... (EURONEXT: SAN and NYSE: SNY) today announced that the ... Administration (FDA) rare pediatric disease priority review voucher in ... alirocumab.  The priority review voucher entitles the holder to ... an expedited 6-month review from the filing date instead ...
(Date:7/30/2014)... 30, 2014 W. R. Grace ... of the REVELERIS® Prep purification system , ... chromatographers, and other researchers to perform both flash ... unit. , With the REVELERIS® Prep purification system, ... chromatography modes with a simple touch of the ...
(Date:7/30/2014)... , July 30, 2014  Decision Resources ... and medical directors in the United ... of biosimilar market penetration will be the level ... (MCOs) and the expected lower cost to patients. ... biosimilars that meet their pricing expectations in order ...
Breaking Biology Technology:Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Grace Launches New REVELERIS® Prep Purification System 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... The National Science Foundation,(NSF) has awarded Loma ... of $593,978 to lead a consortium in developing ... universities. Barry L. Taylor, Ph.D., Professor of Microbiology,and ... Affairs,will lead the project with Rohit Shukla, CEO ...
... - Oncothyreon Inc.,(Nasdaq: ONTY ) (TSX:ONY) announced ... studies of PX-12 and preclinical studies of,PX-866 will ... American Association,for Cancer Research (AACR) in San Diego ... a Phase 1 clinical trial of PX-478,in patients ...
... Biopure,Corporation (Nasdaq: BPUR ) announced today that ... its independent auditor., The audit committee of ... review of audit firms that had expertise with ... in Boston, Massachusetts, Vitale, Caturano & Company, Ltd. ...
Cached Biology Technology:Loma Linda University Partners With Larta Institute for Technology Marketing Program 2Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 2Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 3
(Date:7/30/2014)... Lewis Carroll,s Through the Looking Glass, collaborators from ... Singapore improved a 35-year-old ecology model to better ... of years. , The new model, called a ... Queen Effect," an evolutionary hypothesis introduced by Lee ... organisms must constantly increase their fitness (or ability ...
(Date:7/30/2014)... A deep-sea octopus protected and tended her eggs until ... published July 30, 2014 in the open-access journal ... Aquarium Research Institute and colleagues. , Octopuses typically have ... females protect and take care of their fertilized eggs ... eggs for 1 to 3 months, but little is ...
(Date:7/30/2014)... announced today that David L. Kaplan, Ph.D., will head ... Engineering as editor-in-chief. With the first issue slated ... feature high-quality research in the rapidly burgeoning field of ... that interact with living or biological systems. , "This ... growth in the field of biomaterials over the past ...
Breaking Biology News(10 mins):Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3Deep-sea octopus has longest-known egg-brooding period 2ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2
... U.S. Department of,Homeland Security (DHS) announced today ... international visitors arriving at Boston,Logan International Airport ... department,s,upgrade from two- to 10-fingerprint collection to ... accurately and efficiently,establishing and verifying visitors, identities., ...
... About the Ocean Sciences Meeting News Media Registration ... 4 February 2008 Abstracts and Schedule Available Online Who,s ... This years meeting will offer a wealth of new ... it is found, from mountain peaks to deep ocean ...
... bring a combination of individual scientific skills, expertise ... these offer the opportunity to build a highly ... address the urgent need for bringing new antibiotic ... antibiotics and other antimicrobial agents have saved millions ...
Cached Biology News:DHS Begins Collecting 10 Fingerprints From International Visitors at Boston Logan International Airport 2Media advisory -- 2008 Ocean Sciences Meeting 2Media advisory -- 2008 Ocean Sciences Meeting 3Media advisory -- 2008 Ocean Sciences Meeting 4Unique fungal collection could hold key to future antibiotics 2Unique fungal collection could hold key to future antibiotics 3
... is an inhibitor of ... concentration of inhibitor required ... must be determined empirically ... micromolar inhibitor is sufficient ...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....
Biology Products: